Join

or

Existing user? Login

Controlled Drugs

FDA announces review of opioid approval process

The US Food and Drug Administration (FDA) has said it will review its approach to approvals of new opioid analgesics in light of the ongoing opioid crisis in the United States.

In a statement, Scott Gottlieb, commissioner of the FDA, said it was “re-evaluating how we consider both the individual and public health impacts of new opioids as they are reviewed for approval”.

In October 2018, the US government to require studies evaluating the efficacy of opioids; the ability to require opioids to be sold in special packaging that allows the drugs to be safely disposed; and new powers to issue a mandatory recall order for any controlled substance.

The latest FDA press announcement, , followed its controversial approval of Dsuvia, a sublingual formulation of the extremely potent synthetic opioid sufentanil.

In October 2017, US president Donald Trump declared the nation’s opioid crisis a public health emergency rather than a national emergency, which would have called for the allocation of federal funding.

Gottlieb said: “We’re also re-evaluating how we consider both the individual and public health impacts of new opioids as they are reviewed for approval.

“To that end, I’ve asked the professional staff at the FDA to evaluate a new framework for opioid analgesic approvals; one that provides a transparent process to delineate clearly, eventually in new guidance, how we intend to consider the benefits and risks of these products in the context of this crisis.”

Outlining the forthcoming guidance, Gottlieb said it would question whether the approval of another opioid would “create added risks for diversion, accidental overdose, abuse and misuse” and whether any benefits would “outweigh the risks”.

Citation: Jizak DOI: 10.1211/PJ.2018.20205699

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Suppositories

    A detailed review of suppository dosage forms. For all those involved in the formulation, development, manufacture and testing of suppositories.

    £71.00
  • Health Policy and Ethics

    A comprehensive review of health policy, ethics, economics, and health care delivery around the world.

    £33.00
  • Application and Review of Pediatric Pharmacotherapy

    Increase your understanding of pharmacotherapy prescribed to pediatric patients with these realistic case studies.

    £33.00
  • Conducting Your Pharmacy Practice Research Project

    A systematic guide to the stages of the research process, from planning of the project through to dissemination of the findings.

    £26.00
  • Tablet and Capsule Machine Instrumentation

    A practical guide to the techniques and applications of instrumentation used in the tabletting and capsule filling process.

    £71.00

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.